Both papers documented possible associations of factors specific for the lectin pathway of complement (especially on genetic background) with multiple myeloma or lymphoma (MBL, ficolin-1, ficolin-2) or hospital infections (MASP-2, ficolin-3). Here, FCN2 is linked to lymphoma.